The hedgehog/Gli signaling paradigm in prostate cancer

Expert Review of Endocrinology and Metabolism

Volumn 6, Issue 3, 2011, Pages 453-467

  Chen, Mengqian ^a   Carkner, Richard ^a   Buttyan, Ralph ^a,b  

^a ORDWAY RESEARCH INSTITUTE   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

Author keywords

androgen signaling; cyclopamine; Gli; hedgehog signaling; prostate cancer; Smoothened

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; BETA CATENIN; CYCLIN D2; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLOPAMINE; MYC PROTEIN; OSTEOPONTIN; PROTEIN P16; PROTEIN PATCHED 1; RGS4 PROTEIN; SECRETED FRIZZLED RELATED PROTEIN 1; SMOOTHENED PROTEIN; SONIC HEDGEHOG PROTEIN; TESTOSTERONE; TRANSCRIPTION FACTOR GLI1; TRANSCRIPTION FACTOR GLI2; TRANSCRIPTION FACTOR GLI3; TRANSCRIPTION FACTOR JUNB; TRANSCRIPTION FACTOR NKX2.2; TRANSFORMING GROWTH FACTOR BETA;

ANDROGEN THERAPY; BASAL CELL CARCINOMA; CANCER CELL; CANCER CELL CULTURE; CELL GROWTH; CELL SURVIVAL; CORRELATION ANALYSIS; GENE EXPRESSION; GENE MUTATION; HUMAN; IN SITU HYBRIDIZATION; IN VITRO STUDY; IN VIVO STUDY; MEDULLOBLASTOMA; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; RHABDOMYOSARCOMA; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; TUMOR XENOGRAFT;

EID: 79956146796     PISSN: 17446651     EISSN: 17448417     Source Type: Journal    
DOI: 10.1586/eem.11.24     Document Type: Review

References (132)

1. Kessler B, Albertsen P. The natural history of prostate cancer. Urol. Clin. North Am. 30(2), 219-226 (2003). (Pubitemid 36520596)
2. Brawley OW, Ankerst DP, Thompson IM. Screening for prostate cancer. CA Cancer J. Clin. 59(4), 264-273 (2009).
3. Shteynshlyuger A, Andriole GL. Prostate cancer: to screen or not to screen? Urol. Clin. North Am. 37(1), 1-9 (2010).
4. Wolf AM, Wender RC, Etzioni RB, et al. American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J. Clin. 60(2), 70-98 (2010).
5. McConnell JD. Physiologic basis of endocrine therapy for prostatic cancer. Urol. Clin. North Am. 18(1), 1-13 (1991).
6. Culig Z, Bartsch G. Androgen axis in prostate cancer. J. Cell Biochem. 99(2), 373-381 (2006). (Pubitemid 44435555)
7. Mohler JL. Castration-recurrent prostate cancer is not androgen-independent. Adv. Exp. Med. Biol. 617, 223-234 (2008).
8. Yuan X, Balk SP. Mechanisms mediating androgen receptor reactivation after castration. Urol. Oncol. 27(1), 36-41 (2009).
9. Attar RM, Takimoto CH, Gottardis MM. Castration-resistant prostate cancer: locking up the molecular escape routes. Clin. Cancer Res. 15(10), 3251-3255 (2009).
10. Knudsen KE, Scher HI. Starving the addiction: new opportunities for durable suppression of AR signaling in prostate cancer. Clin. Cancer Res. 15(15), 4792-4798 (2009).
11. Clement V, Sanchez P, de Tribolet N, Radovanovic I, Ruiz i Altaba A. HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr. Biol. 17(2), 165-172 (2007). (Pubitemid 46107823)
12. Morton JP, Mongeau ME, Klimstra DS, et al. Sonic hedgehog acts at multiple stages during pancreatic tumorigenesis. Proc. Natl Acad. Sci. USA 104(12), 5103-5108 (2007). (Pubitemid 47186183)
13. Varnat F, Duquet A, Malerba M, et al. Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion. EMBO Mol. Med. 1(6-7), 338-351 (2009).
14. Bar EE, Chaudhry A, Lin A, et al. Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells 25(10), 2524-2533 (2007). (Pubitemid 47582744)
15. Stecca B, Mas C, Clement V, et al. Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways. Proc. Natl Acad. Sci. USA 104(14), 5895-5900 (2007). (Pubitemid 47175630)
16. Kasper M, Jaks V, Fiaschi M, Toftgard R. Hedgehog signalling in breast cancer. Carcinogenesis 30(6), 903-911 (2009).
17. Ingham PW, McMahon AP. Hedgehog signaling in animal development: paradigms and principles. Genes Dev. 15(23), 3059-3087 (2001). (Pubitemid 33115673)
18. Jiang J, Hui CC. Hedgehog signaling in development and cancer. Dev. Cell 15(6), 801-812 (2008).
19. Wilson CW, Chuang PT. Mechanism and evolution of cytosolic Hedgehog signal transduction. Development 137(13), 2079-2094 (2010).
20. Nusslein-Volhard C, Wieschaus E. Mutations affecting segment number and polarity in Drosophila. Nature 287(5785), 795-801 (1980). (Pubitemid 11214475)
21. Lee JJ, von Kessler DP, Parks S, Beachy PA. Secretion and localized transcription suggest a role in positional signaling for products of the segmentation gene hedgehog. Cell 71(1), 33-50 (1992).
22. Marigo V, Roberts DJ, Lee SM, et al. Cloning, expression, and chromosomal location of SHH and IHH: two human homologues of the Drosophila segment polarity gene hedgehog. Genomics 28(1), 44-51 (1995).
23. Bitgood MJ, Shen L, McMahon AP. Sertoli cell signaling by Desert hedgehog regulates the male germline. Curr. Biol. 6(3), 298-304 (1996).
24. Breitling R. Greased hedgehogs: new links between hedgehog signaling and cholesterol metabolism. Bioessays 29(11), 1085-1094 (2007). (Pubitemid 350057379)
25. Burke R, Nellen D, Bellotto M, et al. Dispatched, a novel sterol-sensing domain protein dedicated to the release of cholesterol-modified hedgehog from signaling cells. Cell 99(7), 803-815 (1999). (Pubitemid 30017650)
26. Carpenter D, Stone DM, Brush J, et al. Characterization of two patched receptors for the vertebrate hedgehog protein family. Proc. Natl Acad. Sci. USA 95(23), 13630-13634 (1998). (Pubitemid 28523023)
27. Wong SY, Reiter JF. The primary cilium at the crossroads of mammalian hedgehog signaling. Curr. Top Dev. Biol. 85, 225-260 (2008).
28. Goetz SC, Anderson KV. The primary cilium: a signalling centre during vertebrate development. Nat. Rev. Genet. 11(5), 331-344 (2010).
29. Ruiz i Altaba A, Sanchez P, Dahmane N. Gli and hedgehog in cancer: tumours, embryos and stem cells. Nat. Rev. Cancer 2(5), 361-372 (2002). (Pubitemid 37328949)
30. Varjosalo M, Taipale J. Hedgehog: functions and mechanisms. Genes Dev. 22(18), 2454-2472 (2008).
31. Corbit KC, Aanstad P, Singla V, Norman AR, Stainier DY, Reiter JF. Vertebrate Smoothened functions at the primary cilium. Nature 437(7061), 1018-1021 (2005). (Pubitemid 41486982)
32. Corcoran RB, Scott MP. Oxysterols stimulate Sonic hedgehog signal transduction and proliferation of medulloblastoma cells. Proc. Natl Acad. Sci. USA 103(22), 8408-8413 (2006). (Pubitemid 43838468)
33. Dwyer JR, Sever N, Carlson M, Nelson SF, Beachy PA, Parhami F. Oxysterols are novel activators of the hedgehog signaling pathway in pluripotent mesenchymal cells. J. Biol. Chem. 282(12), 8959-8968 (2007). (Pubitemid 47093527)
34. Rohatgi R, Milenkovic L, Corcoran RB, Scott MP. Hedgehog signal transduction by Smoothened: pharmacologic evidence for a 2-step activation process. Proc. Natl Acad. Sci. USA 106(9), 3196-3201 (2009).
35. Chen JK, Taipale J, Young KE, Maiti T, Beachy PA. Small molecule modulation of Smoothened activity. Proc. Natl Acad. Sci. USA 99(22), 14071-14076 (2002). (Pubitemid 35257626)
36. Wilson CW, Chen MH, Chuang PT. Smoothened adopts multiple active and inactive conformations capable of trafficking to the primary cilium. PLoS ONE 4(4), e5182 (2009).
37. Hallikas O, Palin K, Sinjushina N, et al. Genome-wide prediction of mammalian enhancers based on analysis of transcription-factor binding affinity. Cell 124(1), 47-59 (2006). (Pubitemid 43069309)
38. Winklmayr M, Schmid C, Laner-Plamberger S, et al. Non-consensus GLI binding sites in Hedgehog target gene regulation. BMC Mol. Biol. 11, 2 (2010).
39. Koebernick K, Pieler T. Gli-type zinc finger proteins as bipotential transducers of Hedgehog signaling. Differentiation 70(2-3), 69-76 (2002).
40. Pan Y, Wang C, Wang B. Phosphorylation of Gli2 by protein kinase A is required for Gli2 processing and degradation and the Sonic Hedgehog-regulated mouse development. Dev. Biol. 326(1), 177-189 (2009).
41. Wen X, Lai CK, Evangelista M, Hongo JA, de Sauvage FJ, Scales SJ. Kinetics of hedgehog-dependent fulllength Gli3 accumulation in primary cilia and subsequent degradation. Mol. Cell Biol. 30(8), 1910-1922 (2010).
42. Smelkinson MG, Zhou Q, Kalderon D. Regulation of Ci-SCFSlimb binding, Ci proteolysis, and hedgehog pathway activity by Ci phosphorylation. Dev. Cell 13(4), 481-495 (2007). (Pubitemid 47500813)
43. Zhang Q, Shi Q, Chen Y, et al. Multiple Ser/Thr-rich degrons mediate the degradation of Ci/Gli by the Cul3-HIB/SPOP E3 ubiquitin ligase. Proc. Natl Acad. Sci. USA 106(50), 21191-21196 (2009).
44. Wang C, Pan Y, Wang B. Suppressor of fused and Spop regulate the stability, processing and function of Gli2 and Gli3 full-length activators but not their repressors. Development 137(12), 2001-2009 (2010).
45. Kasper M, Regl G, Frischauf AM, Aberger F. GLI transcription factors: mediators of oncogenic Hedgehog signalling. Eur. J. Cancer 42(4), 437-445 (2006). (Pubitemid 43227920)
46. Ding Q, Motoyama J, Gasca S, et al. Diminished Sonic hedgehog signaling and lack of floor plate differentiation in Gli2 mutant mice. Development 125(14), 2533-2543 (1998). (Pubitemid 28396152)
47. Park HL, Bai C, Platt KA, et al. Mouse Gli1 mutants are viable but have defects in SHH signaling in combination with a Gli2 mutation. Development 127(8), 1593-1605 (2000). (Pubitemid 30234917)
48. Chuang PT, McMahon AP. Vertebrate Hedgehog signalling modulated by induction of a Hedgehog-binding protein. Nature 397(6720), 617-621 (1999).
49. McLellan JS, Zheng X, Hauk G, Ghirlando R, Beachy PA, Leahy DJ. The mode of Hedgehog binding to Ihog homologues is not conserved across different phyla. Nature 455(7215), 979-983 (2008).
50. Haycraft CJ, Banizs B, Aydin-Son Y, Zhang Q, Michaud EJ, Yoder BK. Gli2 and Gli3 localize to cilia and require the intraflagellar transport protein polaris for processing and function. PLoS Genet. 1(4), e53 (2005).
51. Kim J, Kato M, Beachy PA. Gli2 trafficking links Hedgehog-dependent activation of Smoothened in the primary cilium to transcriptional activation in the nucleus. Proc. Natl Acad. Sci. USA 106(51), 21666-21671 (2009).
52. Canettieri G, Di Marcotullio L, Greco A, et al. Histone deacetylase and Cullin3-REN(KCTD11) ubiquitin ligase interplay regulates Hedgehog signalling through Gli acetylation. Nat. Cell Biol. 12(2), 132-142 (2010).
53. Cox B, Briscoe J, Ulloa F. SUMOylation by Pias1 regulates the activity of the Hedgehog dependent Gli transcription factors. PLoS ONE 5(8), e11996 (2010).
54. Chen MH, Wilson CW, Li YJ, et al. Cilium-independent regulation of Gli protein function by Sufu in Hedgehog signaling is evolutionarily conserved. Genes Dev. 23(16), 1910-1928 (2009).
55. Jia J, Kolterud A, Zeng H, et al. Suppressor of Fused inhibits mammalian Hedgehog signaling in the absence of cilia. Dev. Biol. 330(2), 452-460 (2009).
56. Sinha S, Chen JK. Purmorphamine activates the Hedgehog pathway by targeting Smoothened. Nat. Chem. Biol. 2(1), 29-30 (2006).
57. Incardona JP, Gaffield W, Kapur RP, Roelink H. The teratogenic Veratrum alkaloid cyclopamine inhibits sonic hedgehog signal transduction. Development 125(18), 3553-3562 (1998). (Pubitemid 28469956)
58. Roessler E, Du YZ, Mullor JL, et al. Loss-of-function mutations in the human GLI2 gene are associated with pituitary anomalies and holoprosencephaly- like features. Proc. Natl Acad. Sci. USA 100(23), 13424-13429 (2003). (Pubitemid 37444758)
59. Machold R, Hayashi S, Rutlin M, et al. Sonic hedgehog is required for progenitor cell maintenance in telencephalic stem cell niches. Neuron 39(6), 937-950 (2003). (Pubitemid 37130210)
60. Mo R, Freer AM, Zinyk DL, et al. Specific and redundant functions of Gli2 and Gli3 zinc finger genes in skeletal patterning and development. Development 124(1), 113-123 (1997). (Pubitemid 27053011)
61. Motoyama J, Liu J, Mo R, Ding Q, Post M, Hui CC. Essential function of Gli2 and Gli3 in the formation of lung, trachea and oesophagus. Nat. Genet. 20(1), 54-57 (1998). (Pubitemid 28410344)
62. Podlasek CA, Barnett DH, Clemens JQ, Bak PM, Bushman W. Prostate development requires Sonic hedgehog expressed by the urogenital sinus epithelium. Dev. Biol. 209(1), 28-39 (1999). (Pubitemid 29194310)
63. Berman DM, Desai N, Wang X, et al. Roles for Hedgehog signaling in androgen production and prostate ductal morphogenesis. Dev. Biol. 267(2), 387-398 (2004). (Pubitemid 38328580)
64. Freestone SH, Marker P, Grace OC, et al. Sonic hedgehog regulates prostatic growth and epithelial differentiation. Dev. Biol. 264(2), 352-362 (2003). (Pubitemid 37490974)
65. Barsoum IB, Yao HH. Fetal Leydig cells: progenitor cell maintenance and differentiation. J. Androl. 31(1), 11-15 (2010).
66. Karhadkar SS, Bova GS, Abdallah N, et al. Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 431(7009), 707-712 (2004). (Pubitemid 39382619)
67. Pu Y, Huang L, Prins GS. Sonic hedgehog-patched Gli signaling in the developing rat prostate gland: lobe-specific suppression by neonatal estrogens reduces ductal growth and branching. Dev. Biol. 273(2), 257-275 (2004). (Pubitemid 39140902)
68. Lamm ML, Catbagan WS, Laciak RJ, et al. Sonic hedgehog activates mesenchymal Gli1 expression during prostate ductal bud formation. Dev. Biol. 249(2), 349-366 (2002).
69. Haraguchi R, Motoyama J, Sasaki H, et al. Molecular analysis of coordinated bladder and urogenital organ formation by Hedgehog signaling. Development 134(3), 525-533 (2007). (Pubitemid 46332489)
70. Jenkins D. Hedgehog signalling: emerging evidence for non-canonical pathways. Cell Signal. 21(7), 1023-1034 (2009).
71. Hahn H, Wojnowski L, Miller G, Zimmer A. The patched signaling pathway in tumorigenesis and development: lessons from animal models. J. Mol. Med. 77(6), 459-468 (1999). (Pubitemid 29372578)
72. Zurawel RH, Allen C, Wechsler-Reya R, Scott MP, Raffel C. Evidence that haploinsufficiency of Ptch leads to medulloblastoma in mice. Genes Chromosomes Cancer 28(1), 77-81 (2000). (Pubitemid 30176765)
73. Lee Y, Kawagoe R, Sasai K, et al. Loss of suppressor-of-fused function promotes tumorigenesis. Oncogene 26(44), 6442-6447 (2007). (Pubitemid 47494220)
74. Taylor MD, Liu L, Raffel C, et al. Mutations in SUFU predispose to medulloblastoma. Nat. Genet. 31(3), 306-310 (2002).
75. Reifenberger J, Wolter M, Knobbe CB, et al. Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas. Br. J. Dermatol. 152(1), 43-51 (2005).
76. Pan S, Dong Q, Sun LS, Li TJ. Mechanisms of inactivation of PTCH1 gene in nevoid basal cell carcinoma syndrome: modification of the two-hit hypothesis. Clin. Cancer Res. 16(2), 442-450 (2010).
77. Pastorino L, Ghiorzo P, Nasti S, et al. Identification of a SUFU germline mutation in a family with Gorlin syndrome. Am. J. Med. Genet. A 149A(7), 1539-1543 (2009).
78. Lam CW, Xie J, To KF, et al. A frequent activated smoothened mutation in sporadic basal cell carcinomas. Oncogene 18(3), 833-836 (1999). (Pubitemid 29080343)
79. Watkins DN, Berman DM, Burkholder SG, Wang B, Beachy PA, Baylin SB. Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 422(6929), 313-317 (2003). (Pubitemid 36378358)
80. Kubo M, Nakamura M, Tasaki A, et al. Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer. Cancer Res. 64(17), 6071-6074 (2004). (Pubitemid 39129406)
81. Yauch RL, Gould SE, Scales SJ, et al. A paracrine requirement for hedgehog signalling in cancer. Nature 455(7211), 406-410 (2008).
82. Lauth M, Toftgard R. Non-canonical activation of GLI transcription factors: implications for targeted anti-cancer therapy. Cell Cycle 6(20), 2458-2463 (2007). (Pubitemid 350058663)
83. Dennler S, Andre J, Verrecchia F, Mauviel A. Cloning of the human GLI2 promoter: transcriptional activation by transforming growth factor-b via SMAD3/b-catenin cooperation. J. Biol. Chem. 284(46), 31523-31531 (2009).
84. Zhang J, Lipinski RJ, Gipp JJ, Shaw AK, Bushman W. Hedgehog pathway responsiveness correlates with the presence of primary cilia on prostate stromal cells. BMC Dev. Biol. 9, 50 (2009).
85. Zhang X, Harrington N, Moraes RC, Wu MF, Hilsenbeck SG, Lewis MT. Cyclopamine inhibition of human breast cancer cell growth independent of Smoothened (Smo). Breast Cancer Res. Treat. 115(3), 505-521 (2009).
86. Tremblay MR, Lescarbeau A, Grogan MJ, et al. Discovery of a potent and orally active hedgehog pathway antagonist (IPI-926). J. Med. Chem. 52(14), 4400-4418 (2009).
87. Von Hoff DD, LoRusso PM, Rudin CM, et al. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N. Engl. J. Med. 361(12), 1164-1172 (2009).
88. Lorusso PM, Rudin CM, Reddy JC, et al. Phase I trial of hedgehog pathway inhibitor GDC-0449 in patients with refractory, locally-advanced or metastatic solid tumors. Clin. Cancer Res. 17, 2502-2511 (2011).
89. Mimeault M, Johansson SL, Vankatraman G, et al. Combined targeting of epidermal growth factor receptor and hedgehog signaling by gefitinib and cyclopamine cooperatively improves the cytotoxic effects of docetaxel on metastatic prostate cancer cells. Mol. Cancer Ther. 6(3), 967-978 (2007). (Pubitemid 46554566)
90. Stanton BZ, Peng LF, Maloof N, et al. A small molecule that binds Hedgehog and blocks its signaling in human cells. Nat. Chem. Biol. 5(3), 154-156 (2009).
91. Lauth M, Bergstrom A, Shimokawa T, Toftgard R. Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists. Proc. Natl Acad. Sci. USA 104(20), 8455-8460 (2007). (Pubitemid 47175509)
92. Hyman JM, Firestone AJ, Heine VM, et al. Small-molecule inhibitors reveal multiple strategies for Hedgehog pathway blockade. Proc. Natl Acad. Sci. USA 106(33), 14132-14137 (2009).
93. Murgo AJ. Clinical trials of arsenic trioxide in hematologic and solid tumors: overview of the National Cancer Institute Cooperative Research and Development Studies. Oncologist 6(Suppl. 2), 22-28 (2001). (Pubitemid 32405846)
94. Kim J, Lee JJ, Gardner D, Beachy PA. Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector. Proc. Natl Acad. Sci. USA 107(30), 13432-13437 (2010).
95. Beauchamp EM, Ringer L, Bulut G, et al. Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway. J. Clin. Invest. 121(1), 148-160 (2011).
96. Sanchez P, Hernandez AM, Stecca B, et al. Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling. Proc. Natl Acad. Sci. USA 101(34), 12561-12566 (2004). (Pubitemid 39122063)
97. Mao J, Ligon KL, Rakhlin EY, et al. A novel somatic mouse model to survey tumorigenic potential applied to the Hedgehog pathway. Cancer Res. 66(20), 10171-10178 (2006). (Pubitemid 44672072)
98. Chen BY, Lin DP, Liu JY, et al. A mouse prostate cancer model induced by Hedgehog overexpression. J. Biomed. Sci. 13(3), 373-384 (2006). (Pubitemid 43725253)
99. Sheng T, Li C, Zhang X, et al. Activation of the hedgehog pathway in advanced prostate cancer. Mol. Cancer 3, 29 (2004).
100. Fan L, Pepicelli CV, Dibble CC, et al. Hedgehog signaling promotes prostate xenograft tumor growth. Endocrinology 145(8), 3961-3970 (2004). (Pubitemid 39037585)
101. Azoulay S, Terry S, Chimingqi M, et al. Comparative expression of Hedgehog ligands at different stages of prostate carcinoma progression. J. Pathol. 216(4), 460-470 (2008).
102. Narita S, So A, Ettinger S, et al. GLI2 knockdown using an antisense oligonucleotide induces apoptosis and chemosensitizes cells to paclitaxel in androgen-independent prostate cancer. Clin. Cancer Res. 14(18), 5769-5777 (2008).
103. Shaw A, Gipp J, Bushman W. The Sonic Hedgehog pathway stimulates prostate tumor growth by paracrine signaling and recapitulates embryonic gene expression in tumor myofibroblasts. Oncogene 28(50), 4480-4490 (2009).
104. Zhang J, Lipinski R, Shaw A, Gipp J, Bushman W. Lack of demonstrable autocrine hedgehog signaling in human prostate cancer cell lines. J. Urol. 177(3), 1179-1185 (2007). (Pubitemid 46216370)
105. McCarthy FR, Brown AJ. Autonomous Hedgehog signalling is undetectable in PC-3 prostate cancer cells. Biochem. Biophys. Res. Commun. 373(1), 109-112 (2008).
106. Thiyagarajan S, Bhatia N, Reagan-Shaw S, et al. Role of GLI2 transcription factor in growth and tumorigenicity of prostate cells. Cancer Res. 67(22), 10642-10646 (2007). (Pubitemid 350145887)
107. Stecca B, Mas C, Ruiz i Altaba A. Interference with HH-GLI signaling inhibits prostate cancer. Trends Mol. Med. 11(5), 199-203 (2005). (Pubitemid 40692308)
108. Reddy GP, Barrack ER, Dou QP, et al. Regulatory processes affecting androgen receptor expression, stability, and function: potential targets to treat hormone-refractory prostate cancer. J. Cell Biochem. 98(6), 1408-1423 (2006). (Pubitemid 44141847)
109. Terry S, Yang X, Chen MW, Vacherot F, Buttyan R. Multifaceted interaction between the androgen and Wnt signaling pathways and the implication for prostate cancer. J. Cell Biochem. 99(2), 402-410 (2006). (Pubitemid 44435558)
110. Chen M, Tanner M, Levine AC, Levina E, Ohouo P, Buttyan R. Androgenic regulation of hedgehog signaling pathway components in prostate cancer cells. Cell Cycle 8(1), 149-157 (2009).
111. Chen M, Feuerstein MA, Levina E, et al. Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells. Mol. Cancer 9, 89 (2010).
112. Chen G, Goto Y, Sakamoto R, et al. GLI1, a crucial mediator of sonic hedgehog signaling in prostate cancer, functions as a negative modulator for androgen receptor. Biochem. Biophys. Res. Commun. 404(3), 809-815 (2011).
113. Keys DN, Lewis DL, Selegue JE, et al. Recruitment of a hedgehog regulatory circuit in butterfly eyespot evolution. Science 283(5401), 532-534 (1999).
114. Agren M, Kogerman P, Kleman MI, Wessling M, Toftgard R. Expression of the PTCH1 tumor suppressor gene is regulated by alternative promoters and a single functional Gli-binding site. Gene 330, 101-114 (2004). (Pubitemid 38490423)
115. Bonifas JM, Pennypacker S, Chuang PT, et al. Activation of expression of hedgehog target genes in basal cell carcinomas. J. Invest. Dermatol. 116(5), 739-742 (2001). (Pubitemid 32467653)
116. Bishop CL, Bergin AM, Fessart D, et al. Primary cilium-dependent and -independent Hedgehog signaling inhibits p16(INK4A). Mol. Cell 40(4), 533-547 (2010).
117. Yoon JW, Kita Y, Frank DJ, et al. Gene expression profiling leads to identification of GLI1-binding elements in target genes and a role for multiple downstream pathways in GLI1-induced cell transformation. J. Biol. Chem. 277(7), 5548-5555 (2002). (Pubitemid 34968606)
118. Mill P, Mo R, Hu MC, Dagnino L, Rosenblum ND, Hui CC. Shh controls epithelial proliferation via independent pathways that converge on N-Myc. Dev. Cell 9(2), 293-303 (2005). (Pubitemid 41051747)
119. Rizvi S, Demars CJ, Comba A, et al. Combinatorial chemoprevention reveals a novel smoothened-independent role of GLI1 in esophageal carcinogenesis. Cancer Res. 70(17), 6787-6796 (2010).
120. Sasaki H, Hui C, Nakafuku M, Kondoh H. A binding site for Gli proteins is essential for HNF-3b floor plate enhancer activity in transgenics and can respond to Shh in vitro. Development 124(7), 1313-1322 (1997). (Pubitemid 27190104)
121. Teh MT, Wong ST, Neill GW, Ghali LR, Philpott MP, Quinn AG. FOXM1 is a downstream target of Gli1 in basal cell carcinomas. Cancer Res. 62(16), 4773-4780 (2002).
122. Eichberger T, Regl G, Ikram MS, et al. FOXE1, a new transcriptional target of GLI2 is expressed in human epidermis and basal cell carcinoma. J. Invest. Dermatol. 122(5), 1180-1187 (2004). (Pubitemid 38651093)
123. Laner-Plamberger S, Kaser A, Paulischta M, Hauser-Kronberger C, Eichberger T, Frischauf AM. Cooperation between GLI and JUN enhances transcription of JUN and selected GLI target genes. Oncogene 28(13), 1639-1651 (2009).
124. Vokes SA, Ji H, McCuine S, et al. Genomic characterization of Gli-activator targets in sonic hedgehog-mediated neural patterning. Development 134(10), 1977-1989 (2007). (Pubitemid 46939242)
125. Yoon JW, Gilbertson R, Iannaccone S, Iannaccone P, Walterhouse D. Defining a role for Sonic hedgehog pathway activation in desmoplastic medulloblastoma by identifying GLI1 target genes. Int. J. Cancer 124(1), 109-119 (2009).
126. Vokes SA, Ji H, Wong WH, McMahon AP. A genome-scale analysis of the cisregulatory circuitry underlying sonic hedgehog-mediated patterning of the mammalian limb. Genes Dev. 22(19), 2651-2663 (2008).
127. Yu M, Gipp J, Yoon JW, Iannaccone P, Walterhouse D, Bushman W. Sonic hedgehog-responsive genes in the fetal prostate. J. Biol. Chem. 284(9), 5620-5629 (2009).
128. Katoh Y, Katoh M. WNT antagonist, SFRP1, is Hedgehog signaling target. Int. J. Mol. Med. 17(1), 171-175 (2006).
129. Eichberger T, Kaser A, Pixner C, et al. GLI2-specific transcriptional activation of the bone morphogenetic protein/activin antagonist follistatin in human epidermal cells. J. Biol. Chem. 283(18), 12426-12437 (2008).
130. Regl G, Kasper M, Schnidar H, et al. Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2. Cancer Res. 64(21), 7724-7731 (2004). (Pubitemid 39446903)
131. Tanese K, Fukuma M, Ishiko A, Sakamoto M. Endothelin-2 is upregulated in basal cell carcinoma under control of Hedgehog signaling pathway. Biochem. Biophys. Res. Commun. 391(1), 486-491 (2010).
132. American Cancer Society. Cancer facts and figures 2010 www.cancer.org/acs/groups/content/@nho/documents/document/acspc-024113.pdf